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Summary 
Bruton’s tyrosine kinase (BTK) is a nonreceptor tyro- 
sine klnase crltlcal for B cell development and function. 
Mutations in BTK result in X-linked agammaglobuli- 
nemia (XLA) in humans and X-linked immunodeficiency 
(xid) in mice. Using a random mutagenesisscheme, we 
isolated a gain-of-function mutant called BTK* whose 
expresslon drives growth of NIH 3T3 cells tn soft agar. 
BTK’ results from a single point mutation in the pleck- 
strln homology (PH) domain, where a Glu Is replaced 
by Lys at residue 41. BTK’ shows an Increase in phos- 
phorylatlon on tyroslne residues and an increase in 
membrane targeting. Transforming activity requires 
kinase activity, a putative autophosphorylation site, 
and a functional PH domaln. Mutation of the SH2 or 
SH3 domains did not affect the activity of BTK’. Ex- 
pression of BTK* could also relieve IL-5 dependence 
of a B llneage cell line. These results show that trans- 
formation activation and regulation of BTK are criti- 
cally dependent on the PH domain. 
Introduction 
Nonreceptor protein tyrosine kinases (reviewed by Bolen, 
1993) are key regulators of the development and function 
of lymphocytes. The structure of these kinases is charac- 
terized by the Src homology (SH) tyrosine kinase domain 
and additional SH domains, including SH2 and SH3, which 
serve as protein-protein interaction sites (reviewed by 
Pawson and Gish, 1992). 
BTK belongs to a new subfamily of nonreceptor tyrosine 
kinases, which includes Tecl (Mano et al., 1990) Tecll 
(Manoetal., 1993), Itk(Silicianoetal., 1992) andDSrc26C 
(Gregory et al., 1967). BTK was recently identified as the 
defective gene in human X-linked agammaglobulinemia 
(XLA) (Tsukada et al., 1993; Vetrie et al., 1993) and murine 
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X-linked immunodeficiency (xid) (Rawlings et al., 19! 
Thomas, et al., 1993). In XLA patients, there is less th 
1% of normal levels of mature B cells in the periphe 
blood and immunoglobulin levels are drastically reduci 
In xid mice, B cell numbers are reduced to around 5t 
of normal and certain immunoglobulin subclasses, st 
as immunoglobulin M (IgM) and lgG3, are greatly 
creased. B cells from xid mice are unresponsive to 
terleukin-5 (IL-5; Koike et al., 1995; Hitoshi et al., 195 
IL-10 (Goet al., 1990) CD36(Yamashitaet al., 1995; Hc 
ard et al., 1993) and CD40 (Hasbold and Klaus, 19 
Faris et al., 1994) stimulation. This suggests that BTK n 
be critical for multiple pathways important in B cell fu 
tion. Recent work has demonstrated that IL-5 (Sat0 et 
1994) or IL-6 (Matsuda et al., 1994) stimulation, and I 
receptor (Saouaf et al., 1994) or FcERI (Kawakami et 
1994) cross-linking all lead to BTK activation. 
BTK contains SH2 and SH3 domains, which have bc 
shown to be important for signal transduction in many n 
receptor tyrosine kinases. Binding to tyrosine-phospl 
ylated or nontyrosine-phosphorylated proteins can be I 
diated through SH2 units (Pawson and Gish, 19 
Pendergast et al., 1991). SH3 domains interact with I 
line-rich motifs (Koyama et al., 1993). Proline-rich regi 
of BTK were found to interact with the SH3 domain’ 
the Src family kinases in vitro, but not in vivo (Chen! 
al., 1994). The importance of these interactions aw 
further functional studies. 
The most distinctive feature of the BTK family of tyro! 
kinases is the presence of a pleckstrin homology (PH) 
main in its amino-terminal region. PH domains are fo 
in over 70 proteins involved in signal transduction 
cytoskeletal structures (Haslam et al., 1993; Mayer et 
1993; reviewed by Musacchio et al., 1993; Gibson et 
1994). The PH domain is approximately 120 aa long 
can be divided into six subdomains. The structure oi 
domains determined by nuclear magnetic resonance 1 
pleckstrin (Yoon et al., 1994) and f3-spectrin (Macia 
al., 1994) as well as the crystal structure of the PH dor 
of dynamin (Ferguson et al., 1994) have been solved. 
spite the low amino acid identity among PH domains 1 
different molecules, the three dimensional structure 
PH domains are highly conserved. The core of the 
domain consists of seven anti-parallel 6 sheets and a 
boxy-terminal region folded into an a helix. 
Although the precise function of the PH domain ir 
known, several lines of evidence suggest a critical rol 
it in BTK function. The xid mutation, R26C, and se! 
XLAmutations(Bradleyet al., 1994; de Weerset al., 1 
are located within the PH domain. The carboxy-tern 
region has been shown to interact with the p/T sub1 
of trimeric G proteins (Gpy) (Tsukada et al., 1994; Tou 
et al., 1994). Trp124 of BTK, the only conserved res 
among all PH domains, is required for this G6lr interac 
Also, the amino-terminal region of the PH domain of p 
strin has been shown to bind to phosphatidylinositol 
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bisphosphate (PIP,) (Harian et al., 1994) suggesting that 
lipid modification may regulate PH domain function. Fi- 
nally, the PH domain of BTK can associate with isoforms 
of protein kinase C (PKC) in mast cells and B cells (Yao 
et al., 1994) implying a role for the PH domain in additional 
interactions. 
Study of gain-of-function mutants has been a useful ap- 
proach to investigate signal transduction pathways. An 
activated mutant of mitogen-activated protein kinase 
(MAPK) in Drosophila allowed placement of MAPK down- 
stream of torso and sevenless (Brunner et al., 1994). Simi- 
lar approaches have been used to dissect signal transduc- 
tion pathways in yeast and Caenorhabditis elegans (Brill 
et al., 1994; Ruvkun et al., 1991). Nature has provided us 
with many loss-of-function mutants of BTK, but no gain- 
of-function mutants. We sought mutations that would result 
in BTK activation using a retroviral passage mutagenesis 
and cellular selection scheme scoring for a transformed 
phenotype. Analysis of the BTK* mutation shows the criti- 
cal roleof the PH domain in the regulation of the BTKfamily 
of tyrosine kinases and provides an important genetic tool 
for the study of B lymphoid development. 
Results 
Isolation of an Activated Mutant of BTK 
Many activated tyrosine kinases are capable of trans- 
forming NIH 3T3 cells as measured by growth in soft agar. 
Wild-type BTK was not oncogenic in this assay (data not 
shown). We exploited the high mutational rate of the ret- 
roviral life CyCle to screen for transforming mutants of BTK 
(Goga et al., 1993). NIH 3T3 cells were infected with a 
helper-free retrovirus stock expressing a wild-type BTK 
clone and plated in soft agar. A few rare colonies appeared 
and were picked and expanded in liquid culture. To con- 
firm that the transformed phenotype of these colonies was 
due to mutations in BTK rather than secondary cellular 
events, we used a replication-competent helper virus, Mo- 
loney murine leukemia virus (MuLV), to rescue the inte- 
grated retroviral BTKgene from the transformed cells. One 
of the rescued BTKconstructs demonstrated transforming 
activity upon infection of new NIH 3T3 cells (Figure l), 
demonstrating that the transformed phenotype was asso- 
ciated with a mutation in the retroviral genome. 
A Point Mutation In the PH Domain of BTK Leads 
to the Transformed Phenotype 
lmmunoblotting analysis did not show an obvious change 
in the size of the BTK protein. To determine the precise 
mutation, a phage genomic DNA library was constructed 
from the transformed cells and screened for the integrated 
retroviral construct whose BTK insert was sequenced. A 
single point mutation of G to A at nucleotide position 257 
resulted in a change of glutamic acid at position 41 to 
lysine (Figures 2A and 28). This residue is located in the 
third subdomain of the PH domain and is identical in all 
members of the BTK family of tyrosine kinases. We named 
this transforming allele BTK*. 
To demonstrate unequivocally that the transforming 
phenotype was due to this single point mutation in BTK, 
a chimeric construct was made by fusing the first 173 aa 
from BTK*, including the E41K mutation, with the rest of 
the wild-type BTK sequence. This construct transformed 
NIH 3T3 cells, indicating that the point mutation E41 K in 
the PH domain of BTK is sufficient to activate the trans- 
forming potential of BTK. 
BTK’ Shows Increased Tyroslne Phosphorylation 
Activation of a tyrosine kinase is often associated with 
increased kinase activity, increased tyrosine phosphotyla- 
tion, or both. Wild-type BTK and BTK’ have comparable 
in vitro autophosphotylation kinase activities (Figure 3A). 
Anti-phosphotyrosine immunoblotting of wild-type BTK 
and BTK’ showed that BTK* was highly phosphorylated 
on tyrosine in vivo (Figure 3A). Equal amounts of BTK 
protein were analyzed in these studies as monitored by 
anti-BTK immunoblotting. Following in vivo labeling with 
=P-orthophosphate and recovery by immunoprecipitation, 
phosphoamino acid analysis demonstrated that BTK* has 
increased phosphorylation on Tyr and Ser residues (data 
not shown). 
increased Membrane Targetlng of BTK’ 
Membrane association is often correlated to nonreceptor 
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A 
Figure 2. A Point Mutation Found in the 
Domain of BTK’ 
(A) A linear representation of the BTK pro 
sequence. Domains of BTK are representeN 
follows: SHl, the kinase domain; SH2, the 
homology 2 domain; SH3, the Src homolol 
BTK 
659 AA 
Pro SH3 SH2 SHl 
domain; Pro, the proline rich stretch; PH. 
pleckstrin homology domain. The sha 
boxes represent six subdomains of the PH 
main. The position of BTK’ mutation is 
cated by an arrow. 
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tyrosine kinase activation. More than 95% of wild-type 
BTK was found in the cytosol in resting cells (Kawakami 
et al, 1994; Tsukada et al., 1993). NIH 3T3 cells stably 
expressing wild-type BTK or BTK’ were fractionated by 
hypotonic lysis and Dounce homogenization. The amount 
of BTK protein in each fraction was measured by immu- 
noblotting. There was a 3- to 5fold increase of BTK” pro- 
tein in the membrane fraction compared with wild type 
(Figure 38). Samples were probed for pl2OGAP with an 
anti-GAP antibody to ensure that there was no cytosolic 
contamination of the membrane fraction. These results, 
together with the previous finding that BTK activation cor- 
related with increased membrane association (Kawakami 
et al., 1994), suggest that BTK may function through re- 
versible membrane association. 
BTK’ Oncogenic Activity Requires Its Klnase 
Activity and a Putative Autophosphorylation Site 
Independent pedigrees show that mutations in alternative 
domains of BTK can be associated with XlA (Bradley et 
al., 1994; Saff ran et al., 1994; de Weers et al., 1994; Zhu 
et al., 1994; Vetrieet al., 1993). Todetermine thestructural 
requirements for BTK* activation, we combined this BTK’ 
mutation with secondary mutations in domains implicated 
in regulating BTK function. Inhibition of BTK* transforma- 
tion by a secondary mutation would indicate that a specific 
domain is required to send a downstream signal from BTK’. 
We first looked at mutations outside the PH domain. 
Retroviral constructs of wild-type BTK and BTK’ con- 
taining secondary mutations were made in parallel. The 
transformation activity of these constructs was scored by 
growth in soft agar (Figure 4A). The R307K mutation in 
the SH2 domain of BTK eliminates its ability to bind to 
tyrosine-phosphorylatedproteins(D. Saffran, unpublished 
(B) Sequencing ladder showing the BTK’ m 
tion. Double-stranded DNA sequencing ar 
sis @anger et al.. 1977) of the reconstrul 
transforming allele of BTK (BTK’) (right) 
wild-type BTK (left) showed a single nuclec 
substitution at position 257 as indicated bj 
arrows. 
data). The K430R mutation abolishes kinase activity (c 
not shown). The Y551 F mutation removes a putative a 
phosphorylation site of BTK. A deletion between resid 
204 and 263 removes the SH3 domain. These mutani 
the context of either BTK or BTK’ were introduced 
NIH 3T3 cells and protein expression was measurec 
anti-BTK immunoblotting (Figure 48). The BTK(R3C 
and BTK”(R307K) mutants showed a lower level of exp 
sion compared with the other mutants. This may re 
from reduced protein stability, since another mutatio 
the SH2 domain of BTK has been shown to reduce 
stability (Saffran et al., 1994). 
None of the single mutations except BTK* activate 
transformation in two independent experiments. Am 
the BTK” chimeras, BTK”(R307K) and BTK*(A204-: 
retained transformation activity, while BTK’(K430R) 
BTK*(Y551 F) did not transform NIH 3T3 cells. These 
sults imply that the kinase activity and the putative E 
phosphorylation site, but not the SH2 and the SH3 
mains, are required for efficient BTK* downstr 
signaling. 
The PH Domain Is Essential for BTK’ Signaling 
To assess the functional role of the PH domain in @ 
signaling, we examined the effect of secondary PH doI 
mutations on BTK’ transformation. The R28C muti 
represents the mutation found in xid mice. The W’ 
mutation changes the uniformly conserved tryptol 
found in the carboxy-terminal a-helical portion of Pt 
mains. The W124G mutation was shown to abrogate 
association of the BTK PH domain with Go/y (Tsukac 
al., 1994). These mutations were made in the conte 
wild-type BTK and BTK’ (Figure 5A) and introduced 
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Figure 3. Cellular Tyrosine Phosphorylation and Localization of BTK” 
(A) Increased tyrosine phosphorylation of BTK*. Cells expressing the 
TK-neo (control), wild-type BTK, or BTK’ were lysed and BTK proteins 
were immunoprecipitated with anti-BTK antiserum. Half of the immu- 
noprecipitates were washed and subjected to in vitro autokinase 
assay. The immunoprecipitates and the kinased samples were sub- 
jected to 10% polyaclylamide gel electrophoresis (SDS-PAGE). BTK 
proteins were immunoblotted with anti-BTK antiserum (1:500), followed 
by HAPconjugated goat anti-rabbit secondary antibody (1:5,000), and 
visualized by ECL technique (Amersham) (top). The in vitro autokinase 
activity of BTK proteins were autoradiographed (middle). The in vivo 
tyrosine phosphorylationof BTK was measured by immunobtotting 
with anti-phosphotyrosine antibody 4610 (l:l,OOO), followed by HRP- 
conjugated goat anti-mouse secondary antibody (1;5,00@ and visual- 
ized by ECL technique (bottom). 
(B) Increased membrane targeting of BTK’. NIH 3T3 cells expressing 
wild-type BTK and BTK’ were fractionated by hypotonic lysis and 
Bounce homogenization as described (Kawakami et al., 1994). Total 
cell lysates, the cytosolic fractions, and the membrane fractions were 
analyzed by immunoblotting with anti-BTK antiserum (1:500) or anti- 
GAP antibody (1:250), followed by HRP-conjugated goat anti-rabbit 
secondary antibody (1:5,000), and visualized by ECL technique. 
NIH 3T3 cells. BTK expression was measured by immu- 
noblotting (Figure 58). 
Two independent experiments showed that these PH 
domain mutations did not transform NIH 3T3 cells bythem- 
selves and greatly reduced transformation activity in chi- 
meras with BTK’ (Figure 5A). These data suggest that 
other regions and functions of the PH domain are needed 
for BTK’ downstream signaling. 
Tyroslne Phosphorylatlon of BTK’ Chimeras 
The tyrosine phosphorylation state of BTK* chimeras was 
examined to determine whether it correlates with transfor- 
mation activity. The in vivo tyrosine phosphorylation state 
of the BTK’ chimeras was examined by anti-BTK immuno- 
precipitation followed by anti-phosphotyrosine immuno- 
blotting. Equal amounts of BTK protein were analyzed as 
monitored by anti-BTK immunoblotting (Figure 6, top). The 
SH2 and SH3 domain mutations (BTK*[R307K) and 
BTK*[A204-2631) did not alter the hyperphosphorylation 
state of BTK’ on tyrosine residue(s) (Figure 6, bottom). 
This correlated with their transforming activities. The ki- 
nase mutant chimera (BTK’[K430R]) was not hyperphos- 
phorylated on tyrosine residue(s), suggesting that BTK ki- 
nase activity is responsible for the increased tyrosine 
phosphorylation. Mutation at the putative autophosphory- 
lation site (BTK’[Y551F)) did not affect the hyperphos- 
phorylation of BTK on tyrosine residue(s). This demon- 
strates that BTK* must be phosphorylated on tyrosine 
residue(s) other than the putative autophosphorylation 
site. Neither of the PH domain mutation BTK* chimeras 
were hypertyrosine phosphorylated. These combined re- 
sults suggest that transformation by BTK* chimeras is 
associated with their increased tyrosine phosphorylation, 
but hyperphosphorylation per se is not sufficient for the 
transforming phenotype. 
Role of BTK’ in B Lymphocytes 
Based on the genetic and biochemical findings that BTK 
is involved in the IL-5 signaling pathway(Sato et al., 1994; 
Hitoshi et al., 1993), we investigated the effect of BTK” 
on this B cell growth control pathway. The Y16 cell line 
(Takaki et al, 1990) was derived from an Ild-dependent 
pro-6 cell. Y16 cells were infected with equivalent titer 
(- 106 cfu/ml) retroviruses expressing wild-type 6X, 
BTK*, or the v-abl oncogene, all containing a cis-linked 
neomycin-resistance gene (TK-neo). An additional control 
of a TK-neo-only vector was used. v-abl was chosen as 
a positive control because it is a strong tyrosine kinase 
oncogene that can produce factor independence for many 
hematopoietic cell types. Infected Y16 cells were selected 
with G418 for 10 days and then assayed for IL-5 indepen- 
dence by plating 2 x 104 cells per well on 96well plates. 
Y16 cells expressing wild-type retroviral BTK could not 
grow in the absence of IL-5 (Figure 7A). Two separate 
preparations of BTK’ virus gave rise to multiple IL-5- 
independent clones. V-Abl virus uniformly gave factor in- 
dependent clones within 5 days. The lower frequency of 
growth factor-independent clones associated with BTK’ 
suggests that BTK’ has a much weaker effect on Y16 
cells than v-abl and may require a complementary cellular 
event to establish growth factor independence. IL-5- 
independent clones derived from BTK’ infection were ex- 
panded and the expression of BTK from the retroviral ge- 
nome in these clones was confirmed by Sl nuclease 
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Figure 4. Transformation of NIH 3T3 Cells by BTK’ Chimeras 
(A) A schematic representation of the BTK mutants and their transformation activities. NIH 3T3 cells (IO’) expressing wild-type or mutants c 
were plated in soft agar in each 6 cm plate in duplicate. Colonies larger than 0.2 mm diameter were counted 15 days after plating. The nu 
presented are averages of duplicate plates. 
(6) Expression of BTK mutants. NIH 3T3 cells were infected with different BTK viruses as indicated. Infected cells were selected in 500 
G416 for 2 weeks. Cells (lq were lysed and analyzed by immunoblotting with anti-BTK antiserum (1:500), followed by HRPconjugatec 
anti-rabbit secondary antibody (1:5,000), and visualized by ECL technique. 
protection analysis. BTK retroviral mRNA was expressed 
in all clones that became IL-5 independent (Figure 78, 
top). The amount of RNA in each lane was monitored by 
the expression of glyceraldehyde+phosphatedehydro- 
genase (GAPDH) gene (Figure 78, bottom). 
Discussion 
Activation of BTK Provides Insight 
into Its Regulation 
Cytoplasmic tyrosine kinases can be activated by alterna- 
tive mechanisms. For the Src subfamily, certain mutations 
within the SH3, SH2, or SHl regions can be associated 
with transforming activity(Hirai and Varmus, 1990; O’Brien 
et al., 1990; Levy and Brugge, 1989; Kato et al., 1988). 
In addition, deletion or mutation of a negative regulatory 
phosphorylation site (Tyr527) can lead to up-activation of 
kinase activity and transforming activity (Kmiecik and 
Shalloway, 1987; Piwnica-Worms et al., 1987; Cartwright 
et al., 1987; Reynolds et al., 1987). In contrast, mutations 
in the SH3, or SH2 domains of BTK render the protein 
inactive and are associated with a genetic immunodefi- 
ciency (Zhu et al., 1994; Saff ran et al., 1994). 
The isolation of BTK* and the identification of the activat- 
ing mutation occurring within the PH domain (E41 K) 
vides a unique insight for understanding the regulatic 
this new family of the cytoplasmic tyrosine kinases. 
BTK subfamily of tyrosine kinases has a high degn 
homology within the PH domain. All members, 8) 
DSrc28C have a glutamic acid at amino acid positic 
(Musacchio et al., 1993). It remains to be detent 
whether a similar mutation to BTK” would alter biola 
properties of any of the other family members. Strut 
analysis of PH domains by nuclear magnetic reson 
or X-ray crystallography suggests that a pocket or cl 
the amino-terminal region would consist of charged 
dues including Arg28 and Glu41 as potential ligand 
ing components (Macias et al., 1994; Ferguson E 
1994; Gibson et al., 1994). Alignment of the sequen 
BTK to the threedimensional structure of PH dor 
suggests that the residues involved in the xid mu1 
(Arg28) and BTK’ (Glu41) are likely to be in close cc 
in two antiparallel 8 sheets. There may be an electro 
interaction between these two residues in the normz 
tein important for ligand binding. 
An increase in membrane targeting is another po 
consequence arising from the activation of BTK*. 
kinases, such as Raf, can be recruited to the mem 
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Figure 6. Tyrosine Phosphorylation of BTK’ Chimeras 
NIH 3T3 cells expressing TK-neo (control), wild-type BTK, and BTK 
mutants were lysed and BTK protein was immunoprecipitated with 
anti-BTK antiserum. The immunoprecipitates were subjected to 10% 
SDS-PAGE and analyzed by immunoblotting. The figure shows the 
immunoprecipitated BTKprotein by anti-BTK immunoblotting with anti- 
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Figure 5. PH Domain Mutants Blocks BTK’ 
Transformation 
(A) A schematic representation of the BTK mu- 
tants and their transformation activities. NIH 
3T3 cells (10’) expressing wild-type or mutants 
of BTK were plated in soft agar in each 6 cm 
plate in duplicate. Colonies larger than 0.2 mm 
diameter were counted 15 days after plating. 
The numbers presented are averages of dupli- 
cate plates. 
(B) Expression of BTK mutants. NIH 3T3 cells 
were infected with different BTK viruses as indi- 
cated. Infected cells were selected in 500 ug/ 
ml 6418 for 2 weeks. Cells (lq were lysed 
and analyzed by immunoblotting with anti-BTK 
antiserum (1:WO). followed by HRP-conju- 
gated goat anti-rabbit secondary antibody (1: 
5,000), and visualized by ECL technique. 
by binding to activated partners, like Ras (Traverse et al., 
1993). Covalent lipid modifications can bypass this copart- 
ner requirement (Stokoe et al., 1994; Leevers et al., 1994). 
Our data indicates an increased fraction of BTK’ is found 
in the membrane as compared with wild-type BTK. We do 
not know the precise mechanism for membrane interac- 
tion. However, prior work from our lab and Other8 has indi- 
cated that G9r can interact with the PH domain of BTK 
in such membrane recruitment (Tsukada et al., 1994; 
Touhara et al., 1994). Data from other group8 suggests 
that the PH domain can have direct interaction with se- 
lected phospholipids, including PIP2 and Pmyoinositol 
BTK antiserum (1:500), followed by HRP-conjugated goat anti-rabbit 
secondary antibody (1:5$XtO), and visualized by ECL technique (top), 
and the in vivo tyrosine phosphorylation of BTK by anti-phosphoty- 
rosine immunoblotting (bottom) with 4010 antibody (1 :l JJOO), followed 
by HRP-conjugated goat anti-mouse secondary antibody (1:5,000), 
and visualized by ECL technique. 
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Neo W2 
BTK WT o/72 
BTK* STOCK 1 47l72 
BTK* STOCK 2 26J72 
v-Abl 72l72 
Figure 7. BTK’ Renders Y18 Cells Factor Independent 
(A) Y18 cells infected with TK-neo. wild-type BTK, BTK’, or v-abl vi- 
ruses of equivalent titer were selected with 500 uglml 6418 in the 
presence of 5 U/ml IL-5 for 10 days. Cells (2 x IO’) were plated in 
each of 72 wells on a 98-well plate without IL-5 Wells that became 
confluent 10 days after plating were scored as positive. 
(8) Expression of BTK’ in Y18 cells. Of the total RNA from each cell 
line, 20 ug was subjected to Si nuclease protection analysis (see 
Experimental Procedures): Y18 cells infected with TK-neo virus and 
selected with 0418 (control) or Y18 cells expanded from factor inda 
pendent clones from 98-well plates (see l-l, 1-2, l-3 for cells initially 
infected with BTK’ stock 1 and 2-l. 2-2,2-3 for cells initially infected 
with BTK’ stock 2). 
1,4,5-trisphosphate (Harian et al., 1994; Cifuentes et al., 
1994). The precise relationship between these two sets 
of observations is not yet clear. 
The occurrence of PH domains in signal transduction 
proteins is clear, but their modes of action are not defined. 
The inactivating mutations found in xid mice and XLA pa- 
tients in concert with the activating mutation of BTK’ 
should prove useful in functional analysis of other PH do- 
main-containing proteins. 
Involvement of BTK in Multiple B Cell 
Signaling Pathways 
Genetic and biochemical analyses suggest that BTK plays 
a role in a broad range of B cell signaling pathways. Defec- 
tive responses to specific growth factors and membrane 
cross-linking events, such as .IL6 and surface IgM, are 
well documented through studies of xid mice (Yamashita 
et al., 1995; Koike et al., 1995; Hasbold and Klaus, 1994; 
Howard et al., 1993; Hitoshi et al., 1993; Go et al., 1990). 
The closely related tyrosine kinase ITK has recently been 
described as playing a role in T cell receptor/CD28 signal- 
ing (August et al., 1994). The possible role of BTK in B 
coreceptor pathways should be vigorously investiga 
BTK” should prove useful as a constitutively active f 
of the enzyme that could bypass receptor activation 
cooperate with downstream signal components. 
Our data showing that BTK* can partially relieve grc 
factor IL-5 dependence for the Y16 cell line is compai 
with the genetic defect in IL-5 signaling seen in xid r 
(Hitoshi et al., 1993). However, the relatively weak ei 
of BTK’ as compared with a strong oncogene, sucl 
v&l, suggests that alternative signals must complen 
that emanating from BTK* or that the quantitative strew 
of the signal from BTK’ may not be sufficient for full grc 
factor independence. BTK* was unable to transform 
mature B lymphoid cells directly in in vitro long term t 
marrow culture systems. (A. S., unpublished d 
McLaughlin et al., 1987). Further studies to define 
pathway of action of BTK’ will require more direct kn 
edge of its substrates and genetic cofactors. 
Ex~rlmsntat Procedufss 
NIH 3T3 Call Cuttura and Ratrovhua-Madtatad Gsno Transfc 
NIH 3T3 cells were grown in DMEM media supplemented wit 
fetal calf serum. Recombinant BTK retroviral cDNAs were constr 
by inserting the wild-type and mutant BTK cDNAs intc 
pSRaMSVTK-neo vector (Muller et al., 1991). Helper-free reb 
stocks were prepared by transient hyperexpression (Muller ( 
1991), in which 293T cells were used to increase the viral titer 
et al., 1993). The titer of the viruses were measured by their ab 
confer neomycin resistance to NIH 3T3 cells (-10 cfulml). 
titered viruses were used to infect fibroblast and lymphoid ccl 
rescue the integrated BTKgene in NIH 3T3 cells. a replication o 
tent Moloney MuLV was used to superinfect those cells. The 
that contains the virus carrying the rescued BTK gene was WI 
and used to infect fresh Ntl-l 3T3 cells. Colony-forming abilit 
measured by an agar assay as described (Lug0 and Witte, 1989) 
NIH 3T3 cells. In brief, l(r cells infected with different BTK v 
were plated in Iscove’s media containing 20% fetal calf seru 
0.3% noble agar on an agar bed with 0.8% noble agar and mc 
each 8 cm plate. Colonies were scored positive (more than 0 
in diameter) 2 weeks after plating. 
Y18 Cslls and Factor-lndqwndant Assay 
Y18 (Takaki et al., 1990) cellswere grown in RPM1 1840medias 
mented with 10% fetal calf serum, 50 pM P-rnercaptoethanol, 
U/ml 11-5. Y18 cells (5 x 107 were infected for 3 hr with TI 
wild-type BTK, and BTK’ viruses. Infected cells were selected 
&ml 6418 containing media for 10 days. Cells (2 x 10’) were 
in each of 72 wells of a 98-well plate without 11-5. Confluent well 
counted as factor independent 10 days after plating. 
Genomlc Sicraanlng and gaqusnclng Anatyals 01 BTK cDN 
BTK agar colonies were picked and expanded in liquid cuitur 
genomic DNA from cells derived from one such colony was r 
and cloned into the EcoRl site of the IZAPlUEcoRUClAP clor 
(Stratagene). Library screening followed plaque lifting tech 
(Sambrook et al.. 198Q). with a probe of BTK cDNA labebd by I 
priming kit Prime-It II (Stratagene). Positive phage DNAs we 
vertedtophagemidbyinvivoexcisionaccordingtothevendorp 
(Stratagene). Double-stranded DNA sequencing analysis (Se 
at., 1977) was performed on phagemid DNA using primer setr 
lings et al., 1993) that cover the whole BTK coding sequence 
Yutagsnasls 
Point mutations ETK(R307K). BTK(K43OR), BTK(Y551 F), BTKl 
BTK(W124F) and BTK’(R307K), BTK’(K430R), BTK’O 
BTK*(R28C), BTK’(W124F) were created using sitedirectec 
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genesis kit Sculptor (Amersham) and Alter Sites (Promega) respec- 
tively. BTK(A204-263) was constructed by ligating two 87Kfragments 
(nucleotides l-748and nucleotides 927-1902) into a pBluescriptSK(-) 
vector (Stratagene), which already has partial BTKsequences (nucle- 
otides 1903-2399). These mutants were subcloned into the 
pSRaMSVTK-neo vector (Muller et al., 1991). A Hindlll fragment in 
BTK’ was replaced by that of BTK(A204-263) to create BIK'(A204- 
263) in the pSRaMSVTK-neo vector. 
Protein Analysis 
Total cell lysates were prepared by lysing iod cells in 200 ul boiling 
2x sample buffer (2% SDS, 0.1 M Tris (pH 6.61, 20% glycerol, 5% 
j3-mercaptoethanol, 0.1% bromophenol blue). lmmunoprecipitation 
and immunoblotting were done as described (Konopka and Witte, 
1965). In brief, 10’ cells were lysed on the plate with boiling cell lysis 
buffer (1% Triton X-100, 10 mM phosphate buffer [pH 7.01, 150 mM 
NaCI, 500 uM sodium vanadate) plus 1% SDS. The cell lysates were 
diluted l&fold with cell lysis buffer and clarified by ultracentrifugation 
at 106,006 x g for 30 min at 4OC. The supernatants were incubated 
with 10 ul anti-BTK serum at 4OC for 2 hr. The samples were mixed 
with 100 ul protein A-sepharose beads (suspended in 5 beads volume 
of cell lysis buffer) in the cold room for 1 hr on a nutator and were 
washed three times with ceil lysis buffer. For immunoblotting, immune 
precipitates or ceil lysatss were subjected to 10% SDS-PAGE and 
transferred to nitrocelluiose filter. The filter was blotted with 5% skim 
milkin150mMNaCI,10mMTris(pH7.5)and500~Msodiumvanadate 
for 1 hr, except for anti-phosphotyrosine blotting, which was blocked 
with 2% gelatin in 150 mM NaCI, 10 mM Tris @H 7.5). and 500 pM 
sodium vanadate at 37OC for 1 hr. The filter was then sequentially 
blotted with primary antibodies (anti-BTK rsukada et al, 19931, 1500 
dilution; antiGAP [Transduction Laboratories]. I:250 dilution; anti- 
phosphotyrosine [4GlO], 1:1,000 dilution) and secondary antibodies 
(horseradish peroxidase [HRPj-conjugated goat anti-rabbit or goat 
anti-mouse antibodies [BioRad], 1:5,060 dilution) according to Ko- 
nopka and Witte (1965). Proteins were visualized by enhanced chemi. 
luminescence (ECL) technique (Amersham). In vitro autokinase assay 
was performed as previously described (Konopka and Witte, 1965). 
In brief, BTK immunoprecipitates were prepared as mentioned above. 
The kinass reaction was carried out at 25OC for 5 min in a 45 ul final 
volume with 2 ul lr-91 ATP (3,000 Cilmmol, 5 mCi/ml) and i&fold 
excess (at a final concentration of 4 x IO-’ pmol/ul) cold ATP. 
Subcellular Frsctlonatlon 
Subcellular fractionation was performed as described by Kawakami 
et al. (1994). In brief, IO’ NIH 3T3 cells expressing wild-type BTK or 
BTK’ were scraped into 1 ml hypotonic lysis buffer (1 mM EDTA, 1 
mM EGTA, 10 mM 5glycerophosphate, 1 mM sodium vanadate, 2 
mM MgCI,, 10 mM KCI, 1 mM DTT, 10 fig/ml leupeptin, IO ug/ml 
aprotinin. 40 rig/ml PMSF) and were incubated on ice for 30 min. Cells 
were then Dounce homogenized (30 strokes). Cell lysates were loaded 
onto a 1 M sucrose cushion and spun at 1,600 x g for 10 min. Postnu- 
ctei supematants were spun at 106,000 x g for 30 min. The supsmatant 
contained the cytosolic fraction. The precipitate containing the mem- 
brane fraction was washed with the hypotonic lysis buffer twice and 
resuspended in hypotonic iysis buffer containing 1% SDS in the same 
volume as the cytosolic fraction. It was designated the membrane 
fraction. 
Sl Nuclease Protectlon Anaiysls 
Sl nuclease protection assays were performed according to Weaver 
and Weissmann (1979) using 20 ug of total RNA from the indicated 
Y16 cell lines. The BTK probe corresponded to a 773 bp Bglll-Kpnl 
fragment from pBluescriptSK(-) BTK, which was 5’end labeled at the 
Bglll site with [@*PwTP (6,006 Cilmmol; DuponUNew England Nu- 
clear) and T4 polynucleotide kinase (20 U, Pharmacia). The probe will 
protect a 723 bp fragment of the endogenous BTK mRNA and a 614 
bp fragment of the retrovirally encoded RNA. For the GAPDH probe 
(Fort et al., 1965), a fragment of rat GAPDH was 5’ end labeled at the 
Ncol site. RNA samples were incubated overnight at 52OC with 20,000 
cpm of probes. The Sl digestion was performed as described (Weaver 
and Weissmann, 1979). The products of the reaction were electropho- 
resed on a 5% polyacrylamide sequencing gel and exposed to film 
for 6 hr. 
Acknowledgments 
We thank D. Rawlings, D. Saffran, and D. Afar for their helpful com- 
ments, and J. Shimaoka and J. White for assistance in preparation 
of the manuscript and figures. This work was partially supported by 
United States Public Health Services National Institutional Research 
Service Award CA69056 (T. L.), a postdoctoral fellowship from Ir- 
vington institute for Medical Research (A. S.), USPHS grant CA-12600 
(P. I. Randolph Wall) and a Grant-in-Aid for Scientific and Cancer 
Research from the Japanese Ministry of Education, Science, and Cul- 
ture (K. T.). 0. N. W. is an Investigator of the Howard Hughes Medical 
Institute. 
Received January 16. 1995; revised March 2, 1995. 
References 
August, A., Gibson, S., Kawakami, Y., Kawakami, T., Mills, G. B., and 
Dupont, B. (1994). CD26 is associated with and induces the immediate 
tyrosine phosphorylation and activation of the Tee family kinase ITK/ 
EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. 
USA 91,9347-9351. 
Bolen, J. B. (1993). Nonreceptor tyrosine protein kinases. Oncogene 
8, 2025-2031. 
Bradley, L. A. D., Sweatman, A. K., Lovering, R. C., Jones, A. M., 
Morgan, G., Levinsky, R. J., and Kinnon, C. (1994). Mutation detection 
in the X-linked agammaglobulinemia gene, BTK, using single strand 
conformation polymorphism analysis. Human Mol. Genet. 3, 79-63. 
Brill, J. A., Elion, E.A., and Fink, G. R. (1994).Aroleforautophosphory- 
lation revealed by activated alleles of FUSB, the yeast MAP kinase 
homolog. Mol. Cell. Biol. 5, 297-312. 
Brunner, D., Oellers, N., Szabad, J., Biggs, W. H.. Zipursky, S. L., 
and Hafen, E. (1994). A gain-of-function mutation in Drosophila MAP 
kinase activates multiple receptor tyrosine kinase signaling pathways. 
Cell 76, 675-666. 
Cartwright, C. A., Eckhart, W., Simon, S., and Kaplan, P. L. (1967). Cell 
transformation by ppBoc” mutated in the carboxy-terminal regulatory 
domain. Cell 49, 63-91. 
Cheng, G., Ye, Z-S., and Baltimore, D. (1994). Binding of Bruton’s 
tyrosine kinass to Fyn, Lyn, or Hck through a Src homology 3 domain- 
mediated interaction. Proc. Natl. Acad. Sci. USA 97, 6152-6155. 
Cifuentes, M. E., Delaney, T.. and Rebecchi, M. J. (1994). Dmyo- 
inositol 1,4,5-trisphosphate inhibits binding of phospholipase Cd 1 to 
bilayer membranes. J. Biol. Chem. 269, 1945-1946. 
de Weers, M., Mensink, R. G. J., Kraakman, M. E. M., Schuurman, 
R. K. B., and Hendriks, R. W. (1994). Mutation analysis of the Bruton’s 
tyrosine kinase gene in X-linked agammaglobulinemia: identification 
of a mutation which affects the same codon as is altered in immunodefi- 
cient xid mice. Human Mol. Genet. 3, 161-166. 
Faris, M., Gaskin, F., Parsons, T., and Fu, S. M. (1994). CD40 signaling 
pathway: anti-CD40 monoclonal antibody induces rapid dephosphory- 
lation and phosphorylation of tyrosine-phosphorytated proteins includ- 
ing tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 26kD 
tyrosine phosphorylated protein. J. Exp. Med. 779, 1923-1931. 
Ferguson, K. M., Lemmon, M. A., Schlessinger, J., and Sigler, P. B. 
(1994). Crystal structure at 2.2 A resolution of the pleckstrin homology 
domain from human dynamin. Cell 79, 199-209. 
Fort, P.. Marty, L., Piechaczyk, M., el Sabrouty, S., Dani, C.. Jeanteur. 
P., and Blanchard, J. M. (1965). Various rat adult tissues express only 
one major mRNA species from the glyceraldehyde-3-phosphate 
dehydrogenass multigenic family. Nucl. Acids Res. 13, 1431-1442. 
Gibson, T. J., Hyvonen, M., Musacchio, A., and Saraste, M. (1994). 
PH domains: the first anniversary. TIBS 20, 349-352. 
Go, N. F., Castle, 8. E.. Barret. R., Kastelein, R., Dang, W., Mosmann, 
T. R., Moore, K. W., and Howard, M. (1990). lnterleukin 10, a novel 
B cell stimulatory factor: unresponsiveness of X chromosomelinked 
immunodeficiency B cells. J. Exp. Med. 772, 1625-1631. 
Goga, A., McLaughlin, J., Pendergast, A. M., Parmar, K., Muller, A., 
Rosenberg, N., and Witte, 0. N. (1993). Oncogenic activation of c-ABL 
by mutation within its last exon. Mol. Cell. Biol. 73. 4967-4975. 
Activation of BTK by Its PH Domain Mutation 
459 
Gregory, Ft. J., Kammermeyer, K. L., Vincent, W. S., III, and Wads- 
worth, S. G. (1987). Primary sequence and developmental expression 
of a novel Drosophila melanogaster src gene. Mol. Cell. Biol. 7,2119- 
2127. 
Harian, J. E., Hajduk, P. J., Yoon, H. S., and Fesik, S. W. (1994). 
Pleckstrin homology domains bind to phosphatidylinositol-4, L-bis- 
phosphate. Nature 371, 188-l 70. 
HasbId, J., and Klaus G. G. (1994). B cells from CBA/N mice do not 
proliferate following ligation of CD40. Eur. J. Immunol. 24. 152-157. 
Haslam, R. J., Koide, H. B., and Hemmings, B. A. (1993). Pleckstrin 
homology domain. Nature 363. 309-310. 
Hirai, H., and Varmus, H. (1990). Site directed mutagenesis of the 
SH2 and SH3-coding domains of csrc produces varied phenotypies, 
including oncogenic activation of p80°“;. Mol. Cell. Biol. 70, 1307- 
1318. 
Hitoshi, Y., Sonoda, E., Kikuchi, Y., Yonehara, S., Nakauchi, H.. and 
Takatsu, K. (1993). IL-5 receptor positive B cells, but not eosinophils, 
are functionally and numerically influenced in mice carrying the 
X-linked immune defect. Int. Immunol. 5, 1183-1190. 
Howard, M., Grimaldi, J. C., Bazan, J. F., Lund, F. E., Santos- 
Argumedo, L., Parkhouse, R. M., Walseth, T. F., and Lee, H. C. (1993). 
Formation and hydrolysis of cyclic ADP-ribose catalyzed by lympho- 
cyte antigen CD38. Science, 262, 1058-1059. 
Kato. J. Y., Takeya, T., Grandori, C., Iba, H., Levy, J. B., and Hanafusa. 
H. (1988). Amino acid substitutions sufficient to convert the nontrans- 
forming p80- protein to a transforming protein. Mol. Cell. Biol. 6, 
4155-4180. 
Kawakami, Y., Yao, L., Miura. T., Tsukada. S., Witte. 0. N., and Kawa- 
kami, T. (1994). Tyrosine phosphorylation and activation of Bruton 
tyrosine kinase (Btk) upon FcERI cross-linking. Mol. Cell. Biol. 14, 
5108-5113. 
Kmiecik, T. E., and Shalloway. D. (1987). Activation and suppression of 
pp80Du” transforming ability by mutation of its primary sites of tyrosine 
phosphotylation. Cell 49, 85-73. 
Koike, M., Kikuchi, Y., Tominage, A., Takaki, S., Akagi, K., Miyaxaki, 
J.-l., Yamamura, K.-l., andTakatsu, K. (1994). Defect of IL&receptor- 
mediated signaling in B cells of X-linked immunodeficient (xid) mice. 
Int. Immunol. 7, 2150. 
Konopka, J. B., and Witte, 0. N. (1985). Detection of c-abl tyrosine 
kinase activity in vitro permits direct comparison of normal and altered 
abl gene products. Mol. Cell. Biol. 5, 3118-3123. 
Koyama, S., Yu, H., Daigarno, D. C., Shin, T. B., Zydowsky. L. D., 
and Schreiber. S. L. (1993). Structure of the Pl3K SH3 domain and 
analysis of the SH3 family. Cell 72, 945-952. 
Leevers, S. J., Paterson, H. F, and Marshall, C. J. (1994). Requirement 
for Ras in Raf activation is overcome by targeting Raf to the plasma 
membrane. Nature 369, 411-414. 
Levy, J. B., and Brugge, J. S. (1989). Biological and biochemical prop 
erties of the c-src+ gene product overexpressed in chicken embryo 
fibroblasts. Mol. Cell. Biol. 9, 3332-3341. 
Lugo, T., and Witte, 0. N. (1989). The BCWABLoncogene transforms 
Rat-l cells and cooperates with v-myc. Mol. Cell. Biol. 9, 1283-1270. 
Macias, M. J., Musacchio, A., Ponstingl, H., Nilges, M., Sara&e, M., 
and Oschkinat, H. (1994). Structure of thepleckstrin homology domain 
from j3-spectrin. Nature 369, 875-877. 
Mano. H., Ishikawa, F., Nishida, J., Hirai, H., and Takaku. F. (1990). 
A novel protein-tyrosine kinase, tee, is preferentially expressed in liver. 
Oncogene 5, 1781-I 788. 
Mano, H., Mano, K., Tang, B., Koehler, M., Yi, T., Gilbert, D. J., Jen- 
kins, N. A., Copeland, N. G., and Ihle, J. N. (1993). Expression of a 
novel form of Tee kinase in hematopoietic cells and mapping of the 
gene to chromosome 5 near Kit. Oncogene 8, 417-424. 
Matsuda, T., Takahashi, M., Fukada, T., Tuskada, S., Hirai, H.. Witte, 
0. N., and Hirano, T. (1995). Association and activation of Btk and 
Tee tyrosine kinases by gp130, a signal transducer of the IL-8 family 
of cytokines. Blood 85. 827-833. 
Mayer, B. J., Ren, R., Clark, K. L., and Baltimore, D. (1993). A putative 
modular domain present in diverse signaling proteins. Cell 73, 829- 
830. 
McLaughlin, J., Chianese, E., and Witte, 0. N. (1987). In vitro tran 
mation of immature hematopoietlc cells by the ~210 SCFUABL o 
gene product of the Philadelphia chromosome. Proc. Natl. Acad. 
USA 64, 8558-8582. 
Muller. A. J., Young, J. C., Pendergast, A., Pondel, M., Landau, N 
Lktman, D. R., and Witte, 0. N. (1991). BCR first exon sequel 
specifically activate BcrlAbl tyrosine kinase oncogene of Philadel 
chromosome positive human leukemias. Mol. Cell. Biol. 17, 1’ 
1792. 
Musacchio, A., Gibson, T., Rice, P., Thompson, J., and Sarastc 
(1993). The PH domain is a common piece in the structural patch 
of signaling proteins. TIBS 16, 343-348. 
D’Brien, M. C., Fukui, Y.. and Hanafusa, H. (1990). Activation a 
proto-oncogene p80- by point mutations in the SH2 domain. 
Cell. Biol. IO. 2855-2882. 
Pawson, T., and Gish, G. D. (1992). SH2 and SH3 domains: 
structure to function. Cell 77, 359-382. 
Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1 
Production of high-titer helper-free retroviruses by transient tran 
tion. Proc. Natl. Acad. Sci. USA 90, 8392-8396. 
Pendergast, A. M., Muller, A. J., Havlik, M. H., Maru, Y., and \ 
0. N. (1991). BCR sequences essential for transformation by the 
ABL oncogene bind to the ABL SH2 regulatory domain in a 
phosphotyrosinedependent manner. Cell 66. 181-171. 
Piwnica-Worms, H., Saunders, K. B., Roberts, T. M.. Smith, A. E 
Cheng, S. H. (1987). Tyrosine phosphorylation regulates the bioc 
cal and biological properties of pp80-. Cell 49, 75-82. 
Rawlings, D. J., Saffran, D. C.. Tsukada, S.. Largaespada, D. A 
maldi, J. C., Cohen, L., Mohr. R. N., Bazan, J. F., Howard, M., f 
land, N. G., Jenkins, N. A., and Witte, 0. N. (1993). Mutation I 
unique region of Bruton’styrosine kinase in immunodeficient XID 
Science 267, 358-381. 
Reynolds, A. 8.. Vila, J., Lansing, T. J., Potts, W. M., Weber, I 
and Parsons, J. T. (1987). Activation of the oncogenic poteni 
the avian cellular src protein by specific structural alteration r 
carboxyl-terminus. EMBO J. 6, 2359-2384. 
Ruvkun, G., Wightman, 8.. Burglin, T., and Arasu, P. (1991). Don 
gain-of-function mutations that lead to misregulation of the C. elc 
heterochronic gene lin-14, and the evolutionary implications of 
nant mutations in pattern-formation genes. Development S7, 4 
Saffran, D. C., Parolini, 0.. Fitch-Hilgenberg, M. E., Rawlings, 
Afar, D. E. H., Witte, 0. N.. and Conley, M. E. (1994). A point mu 
in the SH2 domain of Bruton’s tyrosine kinase in atypical X-l 
agammaglobulinemia. N. Engl. J. Med. 330, 1488-1491. 
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular 
ing: A Laboratory Manual, Second Edition (Cold Spring Harbor 
York: Cold Spring Harbor Laboratory Press). 
Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequf 
with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 
5478. 
Saouaf, S. J., Mahajan, S., Rowley, R. B., Kut. S., Fargnoli, J.. 
hardt, A. L., Tsukada, S., Witte, 0. N., and Bolen, J. B. (1994). Ts 
ral differences in the activation of three classes of non-transmem 
protein tyrosine kinase following B cell antigen receptor surfal 
gagement. Proc. Natl. Acad. Sci. USA 91, 9524-9528. 
Sato, S., Katagiri, T., Takaki, S., Kikuchi, Y., Hitoshi, Y., Yoni 
S., Tsukada, S., Kitamura, D., Watanabe, T., Witte, 0.. and Ta 
K. (1994). IL-5 receptor-mediated tyrosine phosphorylation 01 
SH3-containing proteins and activation of Btk and JAK2 kina! 
Exp. Med. 180, 2101-2211. 
Siliciano, J. D., Morrow, T. A., and Desiderio, S. V. (1992). itk, a 
specific tyrosine kinase gene inducible by interleukin 2. Proc 
Acad. Sci. USA 89, 11194-11198. 
Stokoe, D., Macdonald. S. G., Cadwallader, K., Symons, M., an 
cock, J. F. (1994). Activation of Raf as a result of recruitment to r 
membrane. Science 264, 1483-1487. 
Takaki, S..Tominaga, A., Hitoshi, Y.. Mita, S., Sonoda, E., Yams 
N., and Takatsu, K. (1990). Molecular cloning and expression 
murine interleukin-5 receptor. EMBO J. 9, 4387474. 
Immunity 
460 
Thomas, J. D., Sideras, P.. Smith, C. I. E., Vorechovsky, I., Chapman, 
V., and Paul, W. E. (1993). Colocalization of X-linked agammaglobuli- 
nemia and X-linked immunodeficiency genes. Science 267, 355-356. 
Touhara, K., Inglese, J., Pitcher, J. A., Shaw, G., and Lefkowitz, R. J. 
(1994). Binding of G protein fly-subunits to pleckstrin homology do- 
mains. J. Biol. Chem. 269. 10217-10226. 
Traverse, S., Cohen, P., Paterson, H., Marshall, C., Rapp. U., and 
Grand, R. J. (1993). Specific association of activated MAP kinase ki- 
nase kinase (Raf) with the plasma membranes of ras-transformed reti- 
nal cells. Oncogene 8,3175-3181. 
Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., 
Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quart, S., 
Belmont, J. W., Cooper, M. D., Conley, M. E., and Witte, 0. N. (1993). 
Deficient expression of a B cell cytoplasmic tyrosine kinase in human 
X-linked agammaglobulinemia. Cell 72, 279-299. 
Tsukada, S., Simon, M., Witte, O., and Katz, A. (1994). Binding of the 
6/T subunits of heterotrimeric G-proteins to the PH domain of Bruton’s 
tyrosine kinase. Proc. Natl. Acad. Sci. USA 91, 11256-11269. 
Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, 
F., HammarstrOm, L., Kinnon, C., Levinsky, R., Bobrow. M., Smith, 
C. I. E., and Bentley, D. R. (1993). The gene involved in X-linked 
agammaglobulinaemiaisamemberofthesrcfamilyof protein-tyrosine 
kinases. Nature 361, 226-233. 
Weaver, R. F., and Weissmann, C. (1979). Mapping of RNA bya modifi- 
cation of the Berk-Sharp procedure: the 5’ termini of 15 S 6globin 
mRNA precursor and mature 10 s 6-globin mRNA have identical map 
coordinates. Nucl. Acids Res. 7, 1175-I 193. 
Yamashita, Y., Miyake. K., Kikuchi, Y., Takatsu, K., Noda, T., Kosugi, 
A., and Kimoto, M. (1995). A monoclonal antibody against murine 
CD36 homologue delivers a signal into B cells for prolongation of sur- 
vival and protection against apoptosis in vitro: unresponsiveness of 
XID B cells to mAb. Immunology, in press. 
Yao, L., Kawakami, Y., and Kawakami, T. (1994). The pleckstrin homol- 
ogy domain of Bruton tyrosine kinase interacts with protein kinase C. 
Proc. Natl. Acad. Sci. USA 91, 9175-9179. 
Yoon, H. S., Hajduk, P. J., Petros, A. M., Olejniczak. E. T., Meadows, 
R. P., and Fesik. S. W. (1994). Solution structure of a pleckstrin- 
homology domain. Nature 369, 672-675. 
Zhu, Q., Zhang, M., Rawlings, D. J., Vihinen, M., Hagemann, T., Saf- 
fran, D. C.. Kwan, S.-P., Nilsson, L., Smith, C. I. E., Witte, 0. N., Chen, 
S.-H.,andOchs, H. D. (1994). Deletion within theSrc homologydomain 
3 of Bruton’s tyrosine kinase resulting in X-linked Agammaglobuli- 
nemia (XLA). J. Exp. Med. 180,461-470. 
